Portfolio news 0

Enterprise Therapeutics

Enterprise Therapeutics Closes £26 million ($33.1 million) Series B Follow-on Financing

MoA Technology Ltd

Moa Techology - Moa Reveals Data on Next-Generation Herbicides with New Modes of Action and Progress Towards Field Trials

Tissue Regenix Group plc

Tissue Regenix Group plc - Trading update for 2023

Diffblue Ltd

Diffblue - New Diffblue Integration Delivers Enterprise-grade Fully Autonomous AI Java Unit Testing for Easy Continuous Integration

Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies plc - Expansion of leadership team

C-Capture Ltd

C-Capture announces the appointment of Warren East, CBE as Chair

Oxford Nanopore Technologies Plc

Oxford Nanopore and Guy’s and St Thomas’ NHS Foundation Trust showcase a world-first collaboration in infectious disease

Bramble Energy Ltd

Bramble Energy - World’s First Hydrogen Boat Powered By Printed Circuit Board Fuel Cell Technology Completes Real-World Testing

Intelligent Ultrasound Group plc

Intelligent Ultrasound - Trading Update

Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies plc - FY23 trading update